Fentanyl Transdermal Patch and Fedratinib: Interaction Details
- Fedratinib
- Inrebic
- Fentanyl Transdermal Patch
- DuragesicAbstralSubsys +3 more
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Fentanyl Transdermal Patch and Fedratinib interaction:
Fentanyl Transdermal Patch
- Duragesic
- Abstral
- Subsys
- Ionsys
- Actiq
- Fentora
What Happens When You Take Fentanyl Transdermal Patch With Fedratinib
What can happen when they are taken together (rated Major)
Increased exposure
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
Because fedratinib inhibits CYP3A4, giving it together with CYP3A4 substrates can raise the concentrations of those substrates and heighten their risk of adverse reactions. Single-dose studies showed that fedratinib raised the of midazolam, a CYP3A4 substrate, 4-fold. When cannot be avoided, patients should be monitored for adverse reactions, and the dose of any CYP3A4 substrate should be adjusted.1
The Fentanyl Transdermal Patch and Fedratinib Interaction, Explained
Fedratinib (Inrebic) can slow down an enzyme in your liver called . Your body uses that enzyme to break down fentanyl from the Duragesic patch. When it works more slowly, more fentanyl can stay in your body, so the patch may act stronger than expected.
That could mean extra sleepiness, slowed or shallow breathing, dizziness, or confusion. This is a serious interaction, but it can be managed. Keep using both medicines as prescribed, and ask your pharmacist or doctor about it. Your care team may adjust your fentanyl dose and check on you more closely. Call them or get urgent help if you notice unusual drowsiness or trouble breathing.
Mechanism: Fedratinib inhibits , the main pathway for fentanyl . Fentanyl is an active drug (not a ), so increases exposure and effect.
- Magnitude: Fedratinib raised midazolam about 4-fold in single-dose studies. Fentanyl-specific data are not given, but a similar direction is expected.
- Risk: Increased opioid adverse effects, including and . Transdermal fentanyl has a prolonged release and profile, so effects may persist.
- Evidence: Probable. Onset unspecified.
- Management: If is necessary, monitor for adverse reactions (sedation, respiratory rate) and adjust the fentanyl dose as needed. Individualize.
See the 1 reference behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Fentanyl Transdermal Patch and Fedratinib Interact
The likely mechanism
of -mediated by fedratinib
How to Manage the Fentanyl Transdermal Patch and Fedratinib Interaction
Your care team can manage this combination, usually by tailoring your fentanyl dose and watching for side effects.
- Keep taking both medicines exactly as prescribed. Do not change or stop either one on your own.
- Tell your pharmacist and prescriber that you use both so the fentanyl dose can be adjusted and individualized.
- Your team may monitor you more closely for side effects.
- Report unusual sleepiness, slow or shallow breathing, confusion, or dizziness right away.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Fentanyl Transdermal Patch or Fedratinib need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Literature Reports
1 report from the published literature. Each one is headed by the title of the published study it comes from.
What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.
-
Report 1 · Study title
Prescribing information: INREBIC oral capsules, fedratinib oral capsules
When a single 2 mg dose of midazolam (a ) was given together with fedratinib, the midazolam rose 4-fold.1
Fentanyl Transdermal Patch and Fedratinib: Common Questions
How serious is the Fentanyl Transdermal Patch and Fedratinib interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Fentanyl Transdermal Patch and Fedratinib interaction managed?
Your care team can manage this combination, usually by tailoring your fentanyl dose and watching for side effects. Keep taking both medicines exactly as prescribed. Do not change or stop either one on your own. Tell your pharmacist and prescriber that you use both so the fentanyl dose can be adjusted and individualized. Your team may monitor you more closely for side effects. Report unusual sleepi… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "probable". Good supporting evidence, though not definitively proven.
Ask About the Fentanyl Transdermal Patch and Fedratinib Interaction
Ask in your own words about taking Fentanyl Transdermal Patch and Fedratinib together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (1)
- Product Information: INREBIC(R) oral capsules, fedratinib oral capsules. Bristol-Myers Squibb Company (per FDA), Princeton, NJ, 2023. DailyMed
Other Serious Interactions of Fentanyl Transdermal Patch and Fedratinib
Also serious with Fedratinib
Also serious with Fentanyl Transdermal Patch
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, as soon as they can.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven. This interaction.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.